BMO Capital Downgrades Sabra Health Care REIT to Market Perform, Announces $16 Price Target
BMO Capital Downgrades Sabra Health Care REIT to Market Perform, Announces $16 Price Target
BMO Capital將Sabra Health Care REIT的評級下調至市場表現，宣佈目標股價爲16美元
BMO Capital analyst John Kim downgrades Sabra Health Care REIT (NASDAQ:SBRA) from Outperform to Market Perform and announces $16 price target.
蒙特利爾銀行資本分析師John Kim將Sabra Health Care REIT(納斯達克：SBRA)的評級從表現優於大盤下調至市場表現，並宣佈16美元的目標價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。